Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Abstract Text:

M Serova,C M Galmarini,A Ghoul,K Benhadji,S R Green,J Chiao,S Faivre,E Cvitkovic,C Le Tourneau,F Calvo,E Raymond,

This study assessed the antiproliferative activity of sapacitabine (CYC682, CS-682) in a panel of 10 human cancer cell lines with varying degrees of resistance or sensitivity to the commonly used nucleoside analogues ara-C and gemcitabine. Growth inhibition studies using sapacitabine and CNDAC were performed in the panel of cell lines and compared with both nucleoside analogues and other anticancer compounds including oxaliplatin, doxorubicin, docetaxel and seliciclib. Sapacitabine displayed antiproliferative activity across a range of concentrations in a variety of cell lines, including those shown to be resistant to several anticancer drugs. Sapacitabine is biotransformed by plasma, gut and liver amidases into CNDAC and causes cell cycle arrest predominantly in the G(2)/M phase. No clear correlation was observed between sensitivity to sapacitabine and the expression of critical factors involved in resistance to nucleoside analogues such as deoxycytidine kinase (dCK), human equilibrative nucleoside transporter 1, cytosolic 5'-nucleotidase and DNA polymerase-alpha. However, sapacitabine showed cytotoxic activity against dCK-deficient L1210 cells indicating that in some cells, a dCK-independent mechanism of action may be involved. In addition, sapacitabine showed a synergistic effect when combined with gemcitabine and sequence-specific synergy with doxorubicin and oxaliplatin. Sapacitabine is therefore a good candidate for further evaluation in combination with currently used anticancer agents in tumour types with unmet needs.

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Publishing Authors By Initials

M Serova,CM Galmarini,A Ghoul,K Benhadji,SR Green,J Chiao,S Faivre,E Cvitkovic,C Le Tourneau,F Calvo,E Raymond,

For similar organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, alicyclic: cycloparaffins: cyclodecanes: taxoids research abstracts see: organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, alicyclic: cycloparaffins: cyclodecanes: taxoids research

PUBMED ID PMID:

MEDLINE DATE:

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: British journal of cancer

VOLUME: 97

Page Numbers: 628-36

Journal Abbreviation: Br. J. Cancer

ISSN: 0007-0920

DAY: 17

MONTH: 07

YEAR: 2007

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370635

Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Keywords Mesh Terms:

KEYWORDS: Taxoids

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. Information

Substance Name: NT5C2 protein, human

Registry Number: EC 3.1.3.5

Grant and Affiliation Information for Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.

AFFILIATION: RayLab - Department of Medical Oncology, Hôpital Beaujon, 100 boulevard Général Leclerc, Clichy 92110, France.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Antiproliferative effects of sapacitabine CYC682, a novel 2'-deoxycytidine-derivative, in human cancer cells Related Publications

• "Cymothoe sangaris": an extremely stable and highly luminescent 1,2-hydroxypyridinonate chelate of Eu(III).
• "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
• 1,2-HOIQO--a highly versatile 1,2-HOPO analogue.
• An octadentate luminescent Eu(III) 1,2-HOPO chelate with potent aqueous stability.
• Anthrax pathogen evades the mammalian immune system through stealth siderophore production.
• Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.
• Brilliant Sm, Eu, Tb, and Dy chiral lanthanide complexes with strong circularly polarized luminescence.
• Ca2+-calmodulin and janus kinase 2 are required for activation of sodium-proton exchange by the Gi-coupled 5-hydroxytryptamine 1a receptor.
• Could we expect to improve survival in small cell lung cancer?
• Enterobactin protonation and iron release: structural characterization of the salicylate coordination shift in ferric enterobactin.
• Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents.
• GFAP transgenic zebrafish.
• Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity.
• Identification of CYP2C9*2 Allele in HepG2 Cell Line.
• Impaired motor learning in the vestibulo-ocular reflex in mice with multiple climbing fiber input to cerebellar Purkinje cells.
• Late-stage neuronal progenitors in the retina are radial Müller glia that function as retinal stem cells.
• Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.
• Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition.
• Motor deficits in homozygous and heterozygous p/q-type calcium channel mutants.
• Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.
• Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent.
• Serotonin 5-HT1A receptor stimulates c-Jun N-terminal kinase and induces apoptosis in Chinese hamster ovary fibroblasts.
• Siderophore-mediated iron transport in Bacillus subtilis and Corynebacterium glutamicum.
• Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.
• Synthesis and thermodynamic evaluation of mixed hexadentate linear iron chelators containing hydroxypyridinone and terephthalamide units.
• The lanthanide contraction revisited.
• The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans.
• Tren-based analogues of bacillibactin: structure and stability.
• Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.
• X-linked adrenoleukodystrophy.